About Carmell (XAGE)
Carmell Corporation, formerly Carmell Therapeutics Corporation, is a regenerative medicine platform company. The Company is engaged in the development of allogeneic plasma-based bioactive material (PBM) that is designed to boost innate regenerative p... Read more
- USD4.85
- USD4.95
- USD3.40
- USD87.90
- -42.60%
- 0M
- 21.66M
- 109.95k
- 3M
- 2.63
- -95.70%
Stock News
2 hours ago
Alphabet’s stock is charging even higher. Here’s how Google’s AI bets are resonating.
MarketWatch
4 hours ago
Stocks bounce back, and Honeywell's buying spree continues
CNBC
4 hours ago
American Airlines CFO says some travelers are avoiding Newark airport
CNBC
4 hours ago
Ray Dalio says to fear the bond market as deficit becomes critical
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
